Product Images Megestrol Acetate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Megestrol Acetate NDC 17856-0907 by Atlantic Biologicals Corp., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

17856 0907 03

17856 0907 03

This is a description of an oral suspension medication called "MEGESTROL ACETATE". The medication comes in a bottle with the code "17856-0907-03" and a dosage of "400mg/10mL". The medication is to be kept at a temperature between 20 to 25°C and should be protected from heat. The label contains information about alcohol content and instructions on how to use the medication, including a warning to keep it out of children's reach. The manufacturer is listed as "Unit Dose Solutions" and they can be contacted for reordering at 800.509.7592.*

17856 0907 1

17856 0907 1

MEGESTROL ACETATE LIEISE ORAL SUSPENSION, USP is a medication that comes in the form of a 400mg/10ml oral suspension. The package insert should be consulted for indications and dosage. The oral suspension should be stored between 20°C to 25°C (68°F to 77°F) and protected from heat. The medication should be shaken well and contains a maximum of 0.06% alcohol. This medication should be kept out of children's reach. The package contains 48 syringes of the medication with the lot number 008530 and an expiration date of 05/10/2020. The medication was packaged by Unit Dose Solutions and distributed by Atlantic Biologicals Corp. Reordering can be done by calling 800.509.7592.*

this is the structure - structure

this is the structure - structure

This is trial 1 - trial1

This is trial 1 - trial1

This document seems to be a record or report of a medical trial, specifically Trial 1. The only readable text is "Placebo", which might be an indication that this particular trial involved testing the effectiveness of a placebo treatment. However, without further context or information, it is impossible to provide a more detailed description or analysis.*

this is adverse events chart - trial2

this is adverse events chart - trial2

This text suggests that there was a second trial conducted, referred to as "Trial 2," that involved the use of a placebo. The context or purpose of the trial is not given.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.